DOUG vs TECH · rev $995.6M vs P/E 65, rev $1.22B
Douglas Elliman Inc (DOUG) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Douglas Elliman Inc (DOUG) is a real estate services company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported DOUG revenue for 2024-12-31 was $995.6M. Net income was -$77.0M. Revenue was up 4.2% from 2023-12-31 to 2024-12-31. DOUG currently screens at market cap $214.7M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
DOUG currently screens at market cap $214.7M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the DOUG and TECH stock pages for the full models.
Not investment advice.